Perelel, a women’s health supplement company founded by medical professionals, has raised $27 million in growth funding to accelerate its expansion and product development, the company announced on Thursday. The round was led by Prelude Growth Partners, with existing investors Unilever Ventures, Willow Growth Partners, and Selva Ventures also participating.
Founded by Victoria Thain Gioia, Alex Taylor, and Dr. Banafsheh Bayati, Perelel began as a prenatal vitamin brand and has since evolved into a broader women’s health platform. The company’s portfolio now spans supplements designed to support various stages of a woman’s life, including fertility, pregnancy, postnatal recovery, and general wellness.
The fresh capital will be deployed to scale product research, expand distribution, and enhance digital engagement with consumers. Perelel emphasizes evidence-based formulations backed by clinical research, positioning the brand in the growing segment of scientifically validated women’s nutrition.
Victoria Thain Gioia, co-founder, said, “This funding marks a key milestone in Perelel’s evolution. Our mission has always been to provide women with supplements that are rooted in science, transparent, and tailored to their unique needs. With the support of our investors, we are well-positioned to expand our reach and accelerate our innovation pipeline.”
Dr. Banafsheh Bayati added that the company will continue investing in clinical trials and product innovation to ensure that each supplement delivers measurable health benefits.
The women’s supplement market has been growing steadily, driven by rising health awareness, increased disposable income, and a shift toward preventive healthcare. Industry analysts estimate that the global women’s health supplement market could reach over $70 billion by 2030, with demand for evidence-backed, high-quality products leading the growth.
With its new funding, Perelel aims to solidify its position as a leading research-backed supplement brand while expanding beyond its initial prenatal focus into a comprehensive women’s health platform.
